Diabetes pill Avandia to be severely restricted U.S. government health regulators will allow GlaxoSmithKline to continue selling a controversial diabetes pill but will restrict access to the once-blockbuster drug because of heart attack risks. msnbc.com: Diabetes FDA reviewing safety of … Continue reading →